Predictive Oncology earnings were -$12.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest POAI earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$2.2M, down 29.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, POAI reported annual earnings of -$12.7M, with -9.4% growth. The next POAI earnings date is May 13, 2025.
Predictive Oncology Earnings Reports & History FAQ
What were Predictive Oncology's earnings last quarter?
On POAI's earnings call on Invalid Date, Predictive Oncology (NASDAQ: POAI) reported Q4 2024 earnings per share (EPS) of -$0.24, up 71.76% year over year. Total POAI earnings for the quarter were -$2.17 million. In the same quarter last year, Predictive Oncology's earnings per share (EPS) was -$0.85.
The next POAI earnings call is Invalid Date. Add POAI to your watchlist to be reminded of Predictive Oncology's next earnings date.
What was POAI's earnings growth in the past year?
As of Predictive Oncology's earnings date in Invalid Date, Predictive Oncology's earnings has grown year over year. POAI earnings in the past year totalled -$12.66 million.
Is Predictive Oncology profitable or losing money?
As of the last Predictive Oncology earnings report, Predictive Oncology is currently losing money. Predictive Oncology's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$12.66 million, a 9.44% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.